The Yosaki Trust v. Teresa S. Weber

CourtSupreme Court of Delaware
DecidedDecember 15, 2025
Docket157, 2025
StatusPublished

This text of The Yosaki Trust v. Teresa S. Weber (The Yosaki Trust v. Teresa S. Weber) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Yosaki Trust v. Teresa S. Weber, (Del. 2025).

Opinion

IN THE SUPREME COURT OF THE STATE OF DELAWARE

THE YOSAKI TRUST, Russell J. § Miller and Mary Miller as co-trustees, § and THE MIOKO TRUST, Russell J. § Miller and Mary Miller as co-trustees, § § No. 157, 2025 Plaintiffs Below, § Appellants, § Court Below: Court of Chancery § of the State of Delaware v. § § C.A. No. 2024-0738 TERESA S. WEBER, MARC D. § BEER, MARY ELIZABETH § CONLON, HAYMAKER SPONSOR § III LLC, a Delaware Entity, STEVEN § J. HEYER, and COOLEY LLP, a § California entity, § § Defendants Below, § Appellees. §

Submitted: October 8, 2025 Decided: December 15, 2025

Before SEITZ, Chief Justice; VALIHURA, TRAYNOR, LEGROW, and GRIFFITHS, Justices, constituting the Court en Banc.

ORDER

The Court, having considered the briefs and the record below, and after oral

argument, rules as follows:

(1) This appeal arises out of a dispute involving a de-SPAC transaction

(“Transaction”). In a Court of Chancery complaint, the Yosaki Trust and The Mioko

Trust (collectively, the “Trusts”), who held equity interests in BioTE Holdings, LLC (“Holdings”), alleged that conflicted fiduciaries at Holdings breached their fiduciary

duties by closing a recapitalization transaction that unfairly redistributed equity and

conferred control on insiders. The Trusts alleged that they were harmed by diluting

their equity interests and diverting Transaction consideration to insiders. The Court

of Chancery dismissed their complaint on several grounds, one of which was lack of

standing because the Trusts sold their equity interests and therefore no longer had

standing to pursue their claims.

(2) On appeal, the Trusts argue that their claims were direct, not derivative,

and their direct claims involving their converted stock were not extinguished by

selling the converted stock post-Transaction. As explained below, however, even if

their claims were direct, once the Trusts sold their equity interests, they lost standing

to pursue their claims. We affirm the Court of Chancery’s judgment.

(3) Dr. Gary S. Donovitz, M.D., an obstetrician-gynecologist, founded

BioTE in 2012 to train medical professionals to administer pellet-based hormone

therapy.1 BioTE Medical, LLC (“Medical”) is BioTE’s main operating company

and is wholly owned by Holdings.2

1 App. to Opening Br. at A18–19 [hereinafter A__] (Pls.’ Am. Verified Compl. ¶ 9 [hereinafter Compl.]). 2 A20 (Compl. ¶¶ 14–15).

2 (4) Defendant Teresa Weber (“Weber”) was the Chief Executive Officer of

Medical during the relevant times, and Marc Beer (“Beer”) was Medical’s Executive

Chairman of the Board of Managers.3 Defendant Mary Conlon (“Conlon,” and

together with Weber and Beer, the “Insider Defendants”) was the Vice President of

Business Development and General Counsel of Medical and Holdings. 4

(5) Beginning in June, 2021, the Trusts alleged that the Insider Defendants

and BioTE’s outside counsel, Cooley LLP (“Cooley”), negotiated a Business

Combination Agreement (“BCA”) with defendant Haymaker Sponsor III LLC

(“Haymaker Sponsor”) and its CEO, Defendant Steven J. Heyer (“Heyer,” and

together with Haymaker Sponsor, “Haymaker Defendants”). As the Court of

Chancery correctly observed, despite the complaint characterizing the Transaction

as a “[m]erger,”5 it did not involve an exchange of consideration to qualify as a

merger.6 Instead, prior to closing, Holdings redomiciled from Nevada to Delaware7

and recapitalized its existing equity classes (Class A Units, Class AA Units, Class

AAA Units, and Class AAAA Units) into a single class of equity designated as Class

3 A20–21 (Compl. ¶¶ 16–17). 4 A22 (Compl. ¶ 18). 5 See, e.g., A16 (Compl. ¶ 2). 6 See A252–57 (Oral Args. and Rulings of the Ct. on Defs.’ Mots. to Dismiss at 38:12–43:20). 7 A20 (Compl. ¶ 14).

3 A Common Units. 8 Thereafter, Haymaker Acquisition Corp. III (“Haymaker

SPAC”) and Holdings cross-issued equity resulting in “an umbrella partnership C-

corporation, or ‘Up-C’ structure,” with the Haymaker SPAC serving as the publicly

traded entity and Holdings as the flow-through entity indirectly holding substantially

all of the assets.9

(6) Specifically, Holdings issued some of its new Class A Common Units

to the Haymaker SPAC, and in turn, the Haymaker SPAC issued to Holdings the

cash remaining at closing as well as newly created Class V stock. 10 The Class V

stock held voting rights but no equity interest. 11 Holdings thereafter distributed the

Class V stock to holders of the pre-transaction Class A Common Units, which

included the Trusts. 12 The holders of the pre-transaction Class A Common Units had

the right to convert one Class A Common Unit and one Class V share into a single

publicly traded share of the Haymaker SPAC. 13 Haymaker SPAC became the sole

8 App. to Answering Br. at B414 [hereinafter B__] (Business Combination Agreement, Annex A to Schedule 14A, Definitive Proxy Statement, Haymaker Acquisition Corp. III (May 5, 2022) [hereinafter BCA]). 9 B45 (Schedule 14A, Definitive Proxy Statement, Haymaker Acquisition Corp. III (May 5, 2022)). 10 See B434–35 (BCA §§ 2.1, 2.2). 11 See B45 (Schedule 14A, Definitive Proxy Statement, Haymaker Acquisition Corp. III (May 5, 2022)). 12 B434 (BCA § 2.1(d)). 13 B549–50 (Second Am. & Restated Operating Agreement of BioTE Holdings, LLC, Annex I to Schedule 14A, Definitive Proxy Statement, Haymaker Acquisition Corp. III (May 5, 2022)).

4 managing member of Holdings and renamed itself biote Corp (“PubCo”). 14

(7) Before the Transaction, the Trusts each owned 2.8% of Holdings.15

Immediately following closing, through their ownership of Holdings’ Class A

Common Units and the new Class V shares, the Trusts each owned about 2% of the

resulting public company’s equity and voting rights. 16 The Trusts voluntarily

converted their Holdings’ Class A Common Units and Class V Haymaker SPAC

shares into biote Corp. Class A common stock (“PubCo stock”). The Trusts then

voluntarily sold their PubCo stock. 17

(8) In their complaint, the Trusts alleged that, although Holdings expected

to receive over $317.5 million in SPAC funding, primarily because 98% of the

Haymaker SPAC investors redeemed their shares, Holdings received only about $12

million. 18 The Court of Chancery summarized the “principal effect” of the

Transaction as “dilut[ing] the ownership interest . . . [of the] pre-transaction

members of Holdings . . . in return for whatever minimal cash the [Haymaker] SPAC

14 A23–24 (Compl. ¶ 21). 15 A19 (Compl. ¶ 11). 16 See id. 17 A153 (Pls.’ Consol. Answering Br. in Opp’n to Defs.’ Mots. to Dismiss at 42). 18 A16–17 (Compl. ¶ 4).

5 brought to the table.” 19

(9) In July 2024, the Trusts filed a complaint in the Court of Chancery

asserting breach of fiduciary duty claims against the Insider Defendants, aiding and

abetting breaches of fiduciary duty against the Haymaker Defendants and Cooley,

and unjust enrichment against all defendants. In response, the defendants filed

motions to dismiss under Ch. Ct. R. 23.1 and Ch. Ct. R. 12(b)(6).

(10) The Court of Chancery granted the motions. First, the court held that,

because the Trusts’ claims arose out of a cash and equity transaction that diluted their

interests, their claims were derivative under Brookfield Asset Mgmt., Inc. v. Rosson.20

Thus, the Trusts failed to “allege facts supporting a reasonable inference that the

plaintiff has standing to sue derivatively[,]” as required by Ch. Ct. R. 23.1(a)(2).21

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Parnes v. Bally Entertainment Corp.
722 A.2d 1243 (Supreme Court of Delaware, 1999)
Lewis v. Anderson
477 A.2d 1040 (Supreme Court of Delaware, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
The Yosaki Trust v. Teresa S. Weber, Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-yosaki-trust-v-teresa-s-weber-del-2025.